MICHELE RENZE: Open Payments
NPI 1669879045 · DES MOINES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,445 in 15 payments from 12 companies in 2025. Trend: 2023 $712 · 2024 $1,083 · 2025 $1,445
Food & beverage: $1,345Education: $100
| Company | Payments | Amount |
|---|---|---|
| Genentech, Inc. | 3 | $206 |
| ABBVIE INC. | 2 | $201 |
| Deciphera Pharmaceuticals Inc. | 1 | $161 |
| E.R. Squibb & Sons, L.L.C. | 1 | $111 |
| AstraZeneca Pharmaceuticals LP | 1 | $109 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $107 |
| PharmaEssentia USA Corporation | 1 | $100 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| PFIZER INC. | 1 | $98 |
| Gilead Sciences, Inc. | 1 | $97 |
Products named: ELAHERE, QINLOCK, Itovebi, OPDIVO, DATROWAY, Nubeqa, BESREMI, SARCLISA.
Industry payments across IA — which companies pay providers there.
